does future health offer tirzepatide 🚨 Patient Information: Tirzepatide (Mounjaro®) 🚨 Tirzepatide is being offered under the following strict criteria: ✓ You have at least 4 of these 5 conditions – Type 2 Diabetes, Hypertension (high Tirzepatide for Weight Loss &

Mechanism of action: Activates both GLP-1 receptors AND GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously GIP receptors in fat tissue directly regulate lipid metabolism and fat cell energy storage Dual activation creates a synergistic effect on appetite suppression and energy expenditure Produces stronger improvement in insulin sensitivity compared to GLP-1-only medications FDA-approved brand names: Zepbound approved for chronic weight management Mounjaro approved for type 2 diabetes Why does the dual mechanism matter

Wegovy vs mounjaro Wegovy (semaglutide) is approved for managing long-term weight in adults and teens with obesity or being overweight

The results of the large cardiovascular event-driven safety trial comparing tirzepatide with dulaglutide in 12,500 participants in the SURPASS-CVOT study are expected in 2024 (78)

Scopus 110

Use the dosing in units guide to understand the precise amounts at each level

The 4-day window rule If you miss your scheduled injection day, you have a 4-day window, 96 hours, to take the missed dose